Form EFFECT Scinai Immunotherapeutic
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 8, 2025 |
| Accession Number: | 0001213900-25-084488 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Corgi SK Hynix 2x Daily ETF (SK) Is Now Trading: The Lowest-Cost 2x Long SK Hynix ETF at a 0.50% Expense Ratio
- Astound Business Solutions Secures Top Honors in PC Magazine’s 2026 Business Choice Awards
- Rise Gold Provides Details on Upcoming Tungsten and Gold Drilling Program At Idaho-Maryland Mine
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
